0001415889-24-015622.txt : 20240605
0001415889-24-015622.hdr.sgml : 20240605
20240605174808
ACCESSION NUMBER: 0001415889-24-015622
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240603
FILED AS OF DATE: 20240605
DATE AS OF CHANGE: 20240605
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kama Gulsen
CENTRAL INDEX KEY: 0001991106
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38613
FILM NUMBER: 241023205
MAIL ADDRESS:
STREET 1: C/O BIONANO GENOMICS, INC.
STREET 2: 9540 TOWNE CENTRE DRIVE, SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bionano Genomics, Inc.
CENTRAL INDEX KEY: 0001411690
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 261756290
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9540 TOWNE CENTRE DRIVE
STREET 2: SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: (858) 888-7600
MAIL ADDRESS:
STREET 1: 9540 TOWNE CENTRE DRIVE
STREET 2: SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: Bionano Genomics, Inc
DATE OF NAME CHANGE: 20190308
FORMER COMPANY:
FORMER CONFORMED NAME: BioNano Genomics, Inc
DATE OF NAME CHANGE: 20120703
FORMER COMPANY:
FORMER CONFORMED NAME: BioNanomatrix Inc
DATE OF NAME CHANGE: 20070906
4
1
form4-06052024_090604.xml
X0508
4
2024-06-03
0001411690
Bionano Genomics, Inc.
BNGO
0001991106
Kama Gulsen
C/O BIONANO GENOMICS, INC.
9540 TOWNE CENTER DRIVE, SUITE 100
SAN DIEGO
CA
92121
false
true
false
false
Chief Financial Officer
0
Common Stock
2024-06-03
4
A
0
16000
0
A
16000
D
Stock Option (Right to Buy)
.93
2024-06-03
4
A
0
75000
0
A
2034-06-02
Common Stock
75000
75000
D
Represents restricted stock unit award granted under the Issuer's 2018 Equity Incentive Plan.
The shares subject to the RSUs vest 1/4th annually beginning on the one-year anniversary of the grant date.
The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of June 3, 2024 (the "Grant Date") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date.
/s/ Jonathan V. Dixon, Attorney-in-Fact
2024-06-05